Printer Friendly

Browse Pharmaceutical industry topic

Intellectual property subtopic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
FTC Sues Pharmaceutical Companies for Illegally Blocking Consumer Access to Lower-Cost Versions of the Blockbuster Drug AndroGel. Sep 8, 2014 1186
Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery. Sep 5, 2014 1046
DelMar Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent for VAL-083. Sep 3, 2014 644
Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent. Sep 2, 2014 1133
District Court Decision Received In Remodulin Patent Case. Aug 29, 2014 510
Actavis Confirms Generic Neupro Patent Challenge. Aug 22, 2014 953
Nanowire LEDs Patent Investigation. Aug 19, 2014 863
Access Pharmaceuticals Awarded Japan Patent For MuGard And ProctiGard. Aug 14, 2014 996
Global Human Growth Hormone Drugs Industry. Aug 12, 2014 2683
Columbia Laboratories Announces Sale Of IP And Technology For Legatrin P.M. To Lil' Drug Store Products. Aug 6, 2014 279
Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort Topical Spray 0.25%. Jul 30, 2014 720
Columbia Laboratories Expands its Intellectual Property Portfolio Following Receipt of U.S. Patent. Jul 17, 2014 744
Agile Therapeutics Announces Allowance of Additional Patent Claims for Skinfusion. Jul 17, 2014 811
Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office. Jul 15, 2014 1199
Brandsymbol Partners with Med-ERRS to Cultivate Safe Pharmaceutical Trademarks. Jul 11, 2014 580
Actavis Confirms Generic Diclegis Patent Challenge. Jul 11, 2014 912
Pharmalink's Core Patents for Nefecon Treatment for Renal Disease Granted in United States, Europe, China and Hong Kong. Jul 10, 2014 800
Pharmalink's Core Patents for Nefecon Treatment for Renal Disease Granted in United States, Europe, China and Hong Kong. Jul 10, 2014 795
Access Pharmaceuticals Awarded Hong Kong Patent For MuGard. Jul 8, 2014 856
Actavis Confirms Generic Ampyra Patent Challenge. Jul 8, 2014 908
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma. Jul 4, 2014 1510
Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW. Jun 30, 2014 1643
Actavis Confirms Generic Zubsolv Patent Challenge. Jun 30, 2014 934
Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta. Jun 30, 2014 1717
New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell. Jun 26, 2014 1559
Vyvanse Patents Found to Be Infringed and Valid by U.S. District Court. Jun 25, 2014 2192
Vyvanse Patents Found to Be Infringed and Valid by U.S. District Court. Jun 25, 2014 2187
Germany : Bayer CropScience settles Serenade-related litigation with Bion Tech Inc. Jun 24, 2014 319
Agile Therapeutics Announces Issuance of New Patent for Its Skinfusion Transdermal Delivery Device. Jun 20, 2014 777
Actavis Confirms District Court Ruling In Generic Exelon Patch Patent Suit. Jun 19, 2014 813
Ireland : ACTAVIS finalises agreement to settle patent issue. Jun 11, 2014 133
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries. Jun 10, 2014 1903
United States : AMAG Pharmaceuticals issues US patent term extension certificate. Jun 10, 2014 193
Neurodegenerative Diseases Market to 2018 - New Product Entries in both Niche and Broader Parkinson's Disease Treatment will Boost Market Despite Patent Cliff. Jun 9, 2014 4813
United States Patent Issued To Adamas Pharmaceuticals. Jun 9, 2014 611
Actavis Finalizes Agreement Related to Asacol HD Patent Challenge Litigation. Jun 9, 2014 738
ChromaDex Licenses Exclusive Patent Rights from Dartmouth College for Pharmaceutical Use of Nicotinamide Riboside (NR). Jun 3, 2014 1692
Merck patents pigment preparations. Jun 1, 2014 155
Actavis Confirms Generic Onglyza Patent Challenge. May 27, 2014 787
United States : NOVARTIS settles litigation agreement with ACURA. May 26, 2014 283
RXi Pharmaceuticals Granted US Notice of Allowance Covering Self-Delivering (sd-rxRNA) Technology Platform. May 22, 2014 936
English Court Rules Against Lilly in Alimta Vitamin Dosage Regimen Patent Lawsuit. May 15, 2014 753
Actavis Announces Acanya Gel Patent Challenge Settlement. May 12, 2014 918
Valeant Pharmaceuticals Enters Into Patent Settlement Agreements With Actavis. May 12, 2014 676
United States : ACUR inks Settlement deal with RANBAXY. May 9, 2014 166
Global Biosimilars Market 2014-2018: A Number of Biopharmaceutical Patents are Due to Expire in the Near Future or Have Already Expired. Industry overview May 9, 2014 702
Global Biosimilars Market 2014-2018: A Number of Biopharmaceutical Patents are Due to Expire in the Near Future or Have Already Expired. Industry overview May 9, 2014 696
Can-Fite Receives Patent in European Union for Treatment of Liver Function Following Surgery. May 7, 2014 1017
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co. Apr 30, 2014 1572
Multinational Companies Are Developing New Pharmaceutical Pricing and Market Access Strategies For India's Pharmaceutical Market. Apr 30, 2014 746
Avanir Pharmaceuticals Prevails in NUEDEXTA Patent Trial Resulting in Exclusivity Through 2026. Apr 30, 2014 1025
Mylan Challenges FDA Ruling on Exclusivity Relating to Celecoxib. Apr 25, 2014 562
Lilly Reports First-Quarter 2014 Results. Financial report Apr 24, 2014 9800
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie. Apr 24, 2014 1616
Actavis Announces Celebrex Patent Challenge Settlement. Apr 24, 2014 780
Actavis Announces Agreement Related to Generess FE Patent Challenge Litigation. Apr 15, 2014 815
Federal Judge Enforces Settlement Agreement Between Mylan and Endo Regarding Generic FROVA. Apr 11, 2014 588
Xencor Receives Milestone Payment from Merck for Initiation of Phase 1 Clinical Trial of a Biologic Candidate using XmAb Antibody Engineering Intellectual Property. Apr 10, 2014 754
Regulus Presents Positive Preclinical Data on miR-21 and miR-221 Oncology Programs In Oral and Poster Presentations at AACR 2014 Annual Meeting. Apr 7, 2014 1306
United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone for the Second Time. Apr 3, 2014 435
Industry-Leading Companies Announce New Partnership for American Innovation. Apr 3, 2014 659
Germany : CNT intellectual property sold by Bayer to FutureCarbon. Apr 2, 2014 235
U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022. Mar 31, 2014 521
Mylan Comments on U.S. Supreme Court's Consideration of the Standard of Review of Patent Claim Construction. Mar 31, 2014 660
Actavis Confirms Favorable Ruling in Generic Lialda Patent Suit. Mar 28, 2014 718
Noven Pharmaceuticals Announces Issuance of New U.S. Patent, an Important Addition to its Intellectual Property Portfolio for Brisdelle (Paroxetine) Capsules, 7.5 mg. Mar 25, 2014 1951
District Court Upholds Mylan's U.S. Patents on Perforomist Inhalation Solution. Mar 24, 2014 584
Supply Agreements, Patents, Appointments, and FDA Clearances - Analyst Notes on OPKO, Synageva, Hill-Rom, Anacor, and Cardiovascular Systems. Mar 20, 2014 1525
Actavis Announces Daytrana Patent Challenge Settlement. Mar 19, 2014 890
Healthcare Companies Receive Approvals, Recognitions, Agreements, and Announce Senior Level Appointments- Analyst Notes on Pfizer, Boston Scientific, WellPoint, Aetna, and Humana. Mar 18, 2014 1653
Mylan Comments on Favorable Ruling in Generic Celebrex Patent Suit. Mar 13, 2014 535
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta(TM), for Multiple Sclerosis. Mar 10, 2014 912
RXi Pharmaceuticals Granted Key Patent Related to Self-Delivering Technology for the Treatment of Fibrotic Disorders. Mar 5, 2014 749
Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza. Mar 5, 2014 827
Actavis Confirms Generic Multaq Patent Challenge. Feb 28, 2014 909
Actavis Confirms Generic Colcrys Patent Challenge. Feb 28, 2014 870
Can-Fite Granted Patent on the Manufacturing of CF101 in Japan. Feb 25, 2014 950
CII feels International IP Index does not give true picture of India's IP ecosystem. Feb 11, 2014 554
Big pharma seeks US action against India over patents. Feb 6, 2014 659
Actavis Confirms Generic Treanda Patent Challenge. Feb 4, 2014 865
Ferring Pharmaceuticals Inc. Receives Positive Verdict in Patent Infringement Lawsuit for LYSTEDA (tranexamic acid). Feb 3, 2014 822
Japan companies patent coating composition. Feb 1, 2014 144
Fish & Richardson Wins Patent Infringement Suit for Allergan Over Generic LUMIGAN 0.01%. Jan 15, 2014 467
RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders. Jan 14, 2014 782
Mylan Launches Generic Myfortic Delayed-Release Tablets. Company overview Jan 9, 2014 527
Veloxis Pharmaceuticals Receives Notice of Allowance from U.S. Patent Office for Diurnal-Independent Administration of Envarsus. Jan 8, 2014 647
Drug Designation, Conference Participations, Induction of Winners, Software Solution Deployment, and Patent Issuance - Research Report on GSK, Centene, WuXi PharmaTech, Allscripts, and Immunomedics. Report Jan 6, 2014 1554
Triune synergy in biomedical research: uniting pharmaceutical companies, university researchers, and the NIH through the drug repurposing project at NCATS. Yagi, Brian F. Jan 1, 2014 13699
Patent Claims, Agreements, Quarterly Reports, Favorable Clinical Trial Results, and Dividends - Research Report on Acorda, Centene, Neogen, ImmunoGen, and West. Dec 24, 2013 1568
Actavis Confirms Generic NuvaRing Patent Challenge. Dec 24, 2013 928
Can-Fite Granted U.S. Patent for Utilization of A3 Adenosine Receptor as Biomarker to Predict Patient Response to CF101 in Autoimmune Inflammatory Indications. Dec 19, 2013 1008
United Kingdom : Oxford BioMedica inks agreement with GlaxoSmithKline PLC giving option for NON-EXCLUSIVE LICENCE. Dec 19, 2013 113
Biousian Biosystems Receives US Patent for Best-in-Class Analgesic. Dec 16, 2013 752
Biousian Biosystems Receives US Patent for Best-in-Class Analgesic. Dec 16, 2013 758
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma. Dec 11, 2013 819
Chinese Patent Medicine Industry Report, 2012-2015. Industry overview Dec 9, 2013 784
Chinese Patent Medicine Industry Report, 2012-2015. Industry overview Dec 9, 2013 792
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin. Report Dec 6, 2013 1590
Divestitures, Event Participations, Patents, Clinical Studies and Trials - Research Report on Allergan, Zoetis, XOMA, Isis, and Arrowhead. Clinical report Dec 5, 2013 1465
Auxilium Pharmaceuticals, Inc. Announces Court Grants Upsher-Smith Laboratories Motion For Summary Judgment. Dec 4, 2013 1514
Purdue Pharma L.P. Announces Resolution of OxyContin (oxycodone HCl controlled-release) Tablets CII Patent Lawsuit with Impax Laboratories, Inc. Dec 3, 2013 1105
Pharmaceutical pricing system in need of reform: Novartis Vice Chairman. Dec 3, 2013 1318
Global Genitourinary Drugs Market 2011-2015 Report Reveals That One of the Major Challenges Is the Increase in the Patent Expiries of the Best-Selling Drugs in the Market. Dec 3, 2013 516
Global Genitourinary Drugs Market 2011-2015 Report Reveals That One of the Major Challenges Is the Increase in the Patent Expiries of the Best-Selling Drugs in the Market. Dec 3, 2013 522
Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand. Dec 2, 2013 838
Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand. Dec 2, 2013 843
Novogen Files Suite of Patents for Anti-Tropomyosin Drug Technology. Nov 26, 2013 600
Drug Designation, Patents, Milestone Payment, Quarterly Result, and Medical Study - Research Report on The Medicines Company, VIVUS, Isis, HeartWare, and Masimo. Nov 20, 2013 1538
Federal Legislation Support, Philanthropic Activities, and Patent Challenges - Research Report on Mylan, Abbott, Actavis, AbbVie, and Agilent Technologies. Report Nov 19, 2013 1635
Viteava Pharmaceuticals Executes Worldwide Exclusive License. Nov 19, 2013 727
Mylan Launches First Generic Focalin XR Capsules, 30 mg. Nov 18, 2013 400
Actavis Confirms Generic Axiron Patent Challenge. Nov 14, 2013 854
VIRUN[R] & Vital Pharmaceuticals[R] Expand Operations to Offer a Combined 29 Patents for Raw Material Manufacturing and Finished Product Capabilities. Nov 5, 2013 854
U.S. Patent and Trademark Office Grants a Patent for the Reduction of Intraocular Pressure. Nov 5, 2013 1369
Mylan Confirms First-to-File Patent Challenge Relating to Uloric. Nov 1, 2013 578
Actavis Confirms Generic Absorica Patent Challenge. Oct 31, 2013 885
D-Pharm Granted Patent in US and China for its Phase II Product THR-18. Oct 30, 2013 544
Sanofi Q3 2013 Marks the End of the Patent Cliff Period. Oct 30, 2013 1973
D-Pharm Granted Patent in US and China for its Phase II Product THR-18. Oct 30, 2013 549
Actavis Confirms Generic Acanya Gel Patent Challenge. Oct 28, 2013 1047
Recognitions, Patent Issuance, Financial Results, Upcoming Investor Conferences and Update on ClinicalTrial - Research Report on Stereotaxis, Immunomedics, Novadaq, Avanir, and Raptor Pharmaceuticals. Conference news Oct 28, 2013 1639
South Africa: How a Patent Is Blocking Access to a Life-Saving TB Medicine. Oct 24, 2013 460
Mission Pharmacal Settles Patent Infringement Suit Against PureTek. Oct 16, 2013 635
Fuisz Pharma LLC Announces Allowance of Patent Claims by the Israeli Patent Office Relating to the Programming of Bodily Fluid Analyzers. Oct 15, 2013 481
AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso(TM) and its Proprietary Platform Technologies. Oct 8, 2013 1216
Actavis Confirms Generic Suboxone Sublingual Film Patent Challenge. Oct 8, 2013 890
Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platform. Clinical report Oct 1, 2013 1305
Contending issues of intellectual property rights protection and indigenous knowledge of pharmacology in Africa South of the Sahara. Ezeanya, Chika A. Essay Oct 1, 2013 6644
Mylan Launches First Generic VFEND for Oral Suspension. Sep 30, 2013 454
Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst. Report Sep 27, 2013 1606
Mylan Confirms First-to-File Patent Challenge Relating to SAVELLA. Sep 25, 2013 622
ITIP ProFiciency Announces Expanded Website and Marketing Initiatives to Meet Global Demand for IP Cost Management. Sep 23, 2013 571
An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India. Jain, Dipika; Darrow, Jonathan J. Sep 22, 2013 13952
Free Download -- Two impressive case studies on Pharmaceutical Intellectual Property. Sep 18, 2013 439
Free Download -- Two impressive case studies on Pharmaceutical Intellectual Property. Sep 18, 2013 444
NDA Updates, Signed Agreements, Awarded Patents, and Clinical Study Results - Research Report on Merck, Bristol-Myers Squibb, Amarin, GlaxoSmithKline, and Sanofi. Clinical report Sep 17, 2013 1657
Access Pharmaceuticals Awarded Second European Patent for MuGard. Sep 12, 2013 686
Access Pharmaceuticals Awarded Second European Patent for MuGard. Sep 12, 2013 693
European Patent Office Grants a Patent for the Treatment of Sjogren's Syndrome. Sep 3, 2013 462
Bayer's patent on birth control pill Yaz is invalid. Beck, Julie Sep 1, 2013 151
Actavis Confirms Generic Rayos Patent Challenge. Aug 27, 2013 753
Biotech Companies Announce Financial Results and Receive New Patents - Research Report on Regeneron, Medivation, Incyte, Santarus, and ACADIA. Report Aug 21, 2013 1611
Atlantic Pharmaceuticals, Inc. Announces Third Patent Issuance on SMART/Script(TM) Abuse Deterrent Drug Delivery System. Aug 21, 2013 528
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent. Aug 15, 2013 1563
GlaxoSmithKline Suffers Further Asian Blow as India Revokes Patent on Cancer Drug Tykerb. Aug 3, 2013 448
J&J patents sunscreen with UV absorbing polymer. Aug 1, 2013 129
Sanofi Q2 2013: Last Quarter with Significant Negative Impact from the Patent Cliff. Aug 1, 2013 1838
Actavis Confirms Generic Nucynta ER Patent Challenge. Jul 29, 2013 752
Mylan Confirms First-to-File Patent Challenge Relating to BANZEL. Jul 26, 2013 568
Depomed Files Patent Infringement Lawsuit Against Zipsor ANDA Filer. Jul 26, 2013 400
Partnerships, Patent Wins, and Leadership Changes - Research Report on AbbVie, Edwards Lifesciences, Pharmacyclics, MAKO, and Epizyme. Report Jul 17, 2013 1624
Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies. Jul 17, 2013 719
TWi Pharmaceuticals Receives Patent Allowance for Its Reduced Food Effect Metformin Controlled Release Formulation in United States. Jul 16, 2013 655
Mylan Confirms First-to-File Patent Challenge Relating to Vimpat(R). Jul 15, 2013 582
New Collaborations and Patents, Fresh Agreements, Positive Results, and Marketing Recommendations- Research Report on Amgen, Celldex, Vivus, The Medicines Company, and Raptor Pharmaceuticals. Report Jul 15, 2013 1647
Actavis Confirms Generic Vimpat Patent Challenge. Jul 12, 2013 754
Johnson & Johnson Q2 Earnings Preview: Strong-Performing New Drugs And Low Patent Cliff Losses Lift Profits. Financial report Jul 12, 2013 543
US giant loses its patent claim. Jul 10, 2013 251
Dipexium Pharmaceuticals Announces the Issuance of a New U.S. Patent for Locilex(TM). Jul 9, 2013 1249
New Study Shows Pharmaceutical Patent Settlements Netted $25.5 Billion in Savings for U.S. Health System. Jul 9, 2013 761
Everett Laboratories, Inc. Files Patent Infringement Lawsuits Against Competitor Acella Pharmaceuticals, LLC. Jul 8, 2013 506
Xencor Licenses Fc Antibody Engineering IP to Merck. Jul 2, 2013 394
Pfizer case proves disclosure is the best policy. Fenwick, Mike Jul 1, 2013 628
To Avert Daunting Losses, Drug Companies Must Better Manage Patent Expirations of Established Products. Jun 21, 2013 592
Medicago successfully produces plant-based Rotavirus VLP vaccine candidate. Jun 20, 2013 850
Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo Patent. Jun 19, 2013 946
UK Faces Flood of Cheap Viagra Alternatives as Patent Expires. Jun 16, 2013 561
Evaluate Report to Examine Life After the Patent Cliff, Provides Analysis on Pharmaceutical and Biotech Markets and Consensus Forecasts to 2018. Jun 13, 2013 643
Actavis Confirms Generic Diprivan Patent Challenge. Jun 7, 2013 808
Actavis Confirms Generic Safyral Patent Challenge. Jun 5, 2013 763
Drug costs soar because of free trade agreement. Brief article Jun 1, 2013 209
Shire Settles Patent Infringement Lawsuit Against Teva Concerning INTUNIV. May 31, 2013 913
Shire Settles Patent Infringement Lawsuit Against Teva Concerning INTUNIV. May 31, 2013 918
Perrigo Confirms Patent Challenge For Generic Version Of Axiron Topical Solution. May 29, 2013 691
Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application. May 13, 2013 530
Shire Wins Patent Trial Against Watson Concerning LIALDA. May 9, 2013 952
Shire Wins Patent Trial Against Watson Concerning LIALDA. May 9, 2013 957
Daniel Chung, Former Chief Trademark Counsel at Johnson & Johnson, Joins Cantor Colburn LLP. May 2, 2013 640
Recent certifications & approvals. May 1, 2013 343
Catabasis Pharmaceuticals Announces Issuance of Patents for CAT-1000 and CAT-2000 Series. Apr 30, 2013 1075
Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication. Apr 29, 2013 659
Actavis Announces OxyContin Patent Challenge Settlement. Apr 26, 2013 1077
China Chinese Patent Medicine Industry Report, 2012-2015. Industry overview Apr 22, 2013 2762
Adamas Pharmaceuticals Announces Issuance of First US Patent for Nurelin(TM) (Amantadine HCl Extended Release) Program. Apr 22, 2013 804
EPO appeal board decides in favor of the Wengel LNA patent. Apr 18, 2013 601
EPO appeal board decides in favor of the Wengel LNA patent. Apr 18, 2013 608
India's decision on blockbuster cancer drug makes good sense. Apr 17, 2013 995
PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022. Industry overview Apr 10, 2013 1633
ProfNet Experts Available on Pharmaceutical Patents, FBI Email Access, Energy Investments. Apr 10, 2013 2104
The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Roche Holding, Pfizer and Gilead Sciences. Apr 8, 2013 1508
Don't confuse means with ends. Apr 5, 2013 336
USPTO issues Inter Partes Reexamination Certificate of key LNA patent. Apr 5, 2013 727
USPTO issues Inter Partes Reexamination Certificate of key LNA patent. Apr 5, 2013 734
Big Pharma down, not out, after Indian patent blow. Apr 4, 2013 1011
Synthetic Biologics Announces Issuance of U.S. Patent Covering Combination of Estriol and Copaxone for Multiple Sclerosis. Apr 4, 2013 968
MAIL TODAY COMMENT. Apr 3, 2013 729
Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins. Apr 3, 2013 793
Patent Trials In India: Why Multinational Drug Companies Need To Adopt Tailor-Made Business Model For Emerging Economies. Apr 3, 2013 820
Patients pip patent. Apr 2, 2013 680
India drug patent case 'will help poor'. Apr 2, 2013 341
Healthcare campaigners hail Novartis patent rejection by Indian court. Apr 2, 2013 294
India's rejection of drug patent could reverberate, say experts. Apr 2, 2013 787
Swiss pharmaceutical Novartis loses seven-year-old patent fight in India. Apr 1, 2013 329
SC rejection of Novartis patent for cancer drug a win win situation for cheaper foreign drugs in India. Apr 1, 2013 231
Actavis Confirms Generic AndroGel 1.62% Patent Challenge. Apr 1, 2013 997
SC dismisses Novartis' plea to patent cancer drug. Apr 1, 2013 158
'Will continue to invest in India, but cautiously': Novartis after SC ruling. Apr 1, 2013 500
Actavis Confirms Favorable Ruling In Generic Pulmicort RESPULES Patent Suit. Apr 1, 2013 989
International. Bateman, Chris Apr 1, 2013 807
Diabetes Landscape: Market, Technology and Intellectual Property. Mar 28, 2013 6077
Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson's disease treatment will boost market despite patent cliff. Mar 27, 2013 5512
Nutra Pharma Patent and Trademarks Published in India. Mar 25, 2013 807
Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438. Mar 22, 2013 326
In Age of Patent Expiration, Planning Groups for New Pharma Products Growing in Importance. Mar 9, 2013 634
Actavis Confirms Generic Exelon Patch Patent Challenge. Mar 8, 2013 1068
Drug giant loses appeal to halt sale of cheaper pills. Mar 6, 2013 258
German drug maker Bayer to challenge India's ruling allowing cheaper cancer drug copy. Mar 6, 2013 228
Australia : Australia Federal Court holds CRESTOR patents invalid. Mar 6, 2013 225
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex[R] (celecoxib capsules). Mar 5, 2013 265
Actavis Confirms Generic Fortesta Patent Challenge. Mar 1, 2013 860
Patent court to help firms. Feb 21, 2013 104
Amarin and Forest Laboratories Under Review: Drug Makers Face Growing Generic Competition. Feb 15, 2013 773
Amarin and Forest Laboratories Under Review: Drug Makers Face Growing Generic Competition. Feb 15, 2013 778
Actavis Reaches Settlement with Mallinckrodt Over Exalgo 32 mg Dosage Strength. Feb 14, 2013 877
High Profile HealthCare Companies: Leading Pharma Company Secures New Patents. Feb 14, 2013 1792
Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent News Announced for Crown Marketing. Feb 14, 2013 1112
High Profile HealthCare Companies: Leading Pharma Company Secures New Patents. Feb 14, 2013 1787
Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent News Announced for Crown Marketing. Feb 14, 2013 1105
Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets. Feb 13, 2013 410
R-Tech Ueno: Lawsuit Claiming Infringement of AMITIZA[R] Capsules Patents. Feb 12, 2013 515
Targeted Medical Pharma is Assigned Comprehensive Pharmaceutical Billing Patent. Feb 12, 2013 496
Collegium Pharmaceutical Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx, a Tamper-Resistant, Extended-Release Opioid Product. Feb 12, 2013 575
Sucampo Files Patent Infringement Lawsuit Against Anchen Pharmaceuticals and Par Pharmaceuticals. Feb 8, 2013 622
Mystic Pharmaceuticals Receives U.S. Patent for Intranasal Delivery Technology for Pharmaceuticals and Biologics. Feb 7, 2013 390
Celsion Corporation Provides an Update Regarding ThermoDox Agreements with Zhejiang HISUN Pharmaceutical Company for China. Feb 5, 2013 971
Pfizer Wins RAPAMUNE[R] Patent Case in Delaware District Court. Jan 31, 2013 1115
Actavis Confirms District Court Ruling In Generic Rapamune Patent Suit. Jan 31, 2013 903
Targeted Medical Pharma Receives Notice of Issuance for Comprehensive Billing Patent. Jan 30, 2013 511
LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012 Results. Financial report Jan 29, 2013 6868
TetraLogic Pharmaceuticals Announces Decision to Grant Japanese Patent on Birinapant. Clinical report Jan 28, 2013 439
Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim Patents. Jan 28, 2013 1733
Switzerland : Novartis delivers strong innovation in 2012, offsetting patent expirations; next growth phase expected to begin in 2013. Jan 24, 2013 474
Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit. Jan 23, 2013 683
Watson Confirms Opana ER Patent Challenge. Jan 23, 2013 767
Spectrum Pharmaceuticals Announces Extension of FUSILEV[R] (levoleucovorin) for Injection Patent Until 2022. Jan 17, 2013 1091
Technical Review: New Releases from Drug Maker Majors Cushion Against Patent Cliff Effects. Jan 16, 2013 612
Technical Review: New Releases from Drug Maker Majors Cushion Against Patent Cliff Effects. Jan 16, 2013 617
Which Biotech Companies Are Turning the Tables on Patent Cliffs? Jan 14, 2013 963
Which Biotech Companies Are Turning the Tables on Patent Cliffs? Jan 14, 2013 968
Therapies and Biomarkers for Inflammatory Bowel Disease. Jan 8, 2013 4498
EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals. Dec 28, 2012 988
EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals. Dec 28, 2012 993
Watson Confirms Velcade Patent Challenge. Dec 28, 2012 856
Atlantic Pharmaceuticals, Inc. Announces Two Patent Issuances for Its Tamper-Resistant Pharmaceutical Platform. Dec 20, 2012 565
For the Treatment of Osteoporosis, Patent Expiries of Key Agents Will Trigger a Further Decline in Sales for the Bisphosphonates Drug Class Through 2021. Dec 6, 2012 590
Jazz Pharmaceuticals Announces Issuance of Additional Xyrem Patent. Dec 4, 2012 365
Jazz Pharmaceuticals Announces Issuance of Additional Xyrem Patent. Dec 4, 2012 371
Through 2021, Major Constraints in the Hospital-Treated Infections Drug Market Will Include the Loss of Patent Protection for Key Branded Products--Notably Pfizer's Zyvox--and Continued Generic Erosion of Premium-Priced Agents Such as Meropenem. Dec 3, 2012 598
Fighting intellectual property theft. Holbrook, Emily Dec 1, 2012 879
Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings. Nov 29, 2012 970
Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings. Nov 29, 2012 992
Rexahn Pharmaceuticals Issued US Patent for Quinoxalinyl-piperazine Compounds. Nov 21, 2012 604
TCI ClampConnect[TM] Sanitary Fitting from L.J. Star Receives Patent. Nov 20, 2012 435
International Drug & Explosives Detection Company IDenta Corp. Receives Patent for New Sniffer. Nov 20, 2012 745
HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth. Nov 19, 2012 2800
Impax Laboratories and ThoRx Laboratories Confirm Patent Challenge Relating to Generic OPANA[R] ER 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, and 40 mg. Nov 16, 2012 924
Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900. Nov 15, 2012 600
Research and Markets: Global Genitourinary Drugs Market 2011-2015 Report Reveals That One of the Major Challenges is the Increase in the Patent Expiries of the Best-Selling Drugs in the Market. Nov 12, 2012 375
Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC. Oct 29, 2012 1005
LILLY (ELI) & COMPANY - 3rd Quarter Results. Financial report Oct 25, 2012 5518
Fitch: Patent Cliff Causes Eli Lilly Revenue to Tumble. Oct 24, 2012 628
Isis Pharmaceuticals To Receive $1.1 Million From Alnylam. Oct 23, 2012 726
Bayer's Investigational Riociguat Meets Primary Endpoint in Phase III Study in Patients with Pulmonary Arterial Hypertension (PAH). Oct 22, 2012 1052
Concert Pharmaceuticals Announces Issuance of U.S. Patent for its Lead Drug Candidate CTP-499. Oct 22, 2012 579
TetraLogic Pharmaceuticals Granted Third U.S. Patent on Birinapant. Clinical report Oct 9, 2012 355
Spectrum Pharmaceuticals Announces the USPTO Has Granted Five-Year Extension for FOLOTYN[R] Patent. Oct 8, 2012 1220
MEI Pharma Issued European Patent For Lead Mitochondrial Inhibitor Drug Candidate ME-344. Oct 2, 2012 700
Dow AgroSciences Awarded Costs of $5.3 Million Based on Bayer's Inequitable Conduct. Oct 1, 2012 268
Generic Plavix competitors set to distribute. Richmond, M. Brief article Oct 1, 2012 146
Bashing buy-offs: circuit split reignites the debate over reverse-payment settlements. Seidenberg, Steven Sep 29, 2012 1264
Provectus Pharmaceuticals' Patent Application Published for Combining Local and Systemic Therapies for Enhanced Treatment of Cancer. Sep 28, 2012 461
Bayer appeals one of its cases against Dow AgroSciences. Sep 28, 2012 414
Horizon Pharma Announces Receipt of Two Additional U.S. Patent Allowances for DUEXIS. Sep 28, 2012 988
Oral Arguments in the UCSF Appeal of United States Patent and Trademark Office Judgment in Favor of InSite Vision Are Scheduled for November 6, 2012. Sep 27, 2012 801
Rexahn Pharmaceuticals Granted European Patent for Novel Anti-cancer Isoquinolinamine Compounds. Sep 26, 2012 600
Research and Markets: Generics Analysis: Key Patent Case Reviews. Sep 25, 2012 285
United States : For OXECTA, ACURA PHARMACEUTICALS INC. disclosed Paragraph IV ANDA Filing. Sep 22, 2012 118
Generics Analysis: Key Patent Case Reviews. Sep 20, 2012 542
New U.S. Composition of Matter Patent for Aradigm's Pulmaquin[TM] and Lipoquin[TM] Provides Protection Until 2031. Sep 18, 2012 797
Research and Markets: The Global Peripheral Vascular Devices Market to Grow At A CAGR Of 6.5 Percent over the Period 2011-2015. Sep 14, 2012 342
/C O R R E C T I O N -- Jazz Pharmaceuticals/. Correction notice Sep 12, 2012 386
/C O R R E C T I O N -- Jazz Pharmaceuticals/. Correction notice Sep 11, 2012 393
Jazz Pharmaceuticals Announces Issuance of New Formulation Patent for Xyrem. Sep 11, 2012 313
India : PFIZER and MYLAN settles patent dispute. Sep 10, 2012 129
United States : ISIS PHARMA to get $1.4 Mln from ALNYLAM. Sep 7, 2012 150
Perrigo Confirms First To File Patent Challenge For Generic Version Of ProAir HFA Inhalation Aerosol. Sep 6, 2012 745
Aradigm Patent Protection for Smoking Cessation is Extended with Issuance of a Method of Treatment Patent. Sep 5, 2012 622
IPO initiates solid steps for setting up IP tribunals: Afridi. Sep 5, 2012 388
Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets. Company overview Sep 5, 2012 797
Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets. Company overview Sep 5, 2012 804

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters